EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.22.26 | Adenocarcinoma |
16269926 |
Cancer procoagulant in patients with adenocarcinomas. |
causal interaction diagnostic usage unassigned |
3 3 0 |
3.4.22.26 | Carcinoma |
2298496 |
Cancer procoagulant in serum of rats during development of experimental epithelioma. |
ongoing research unassigned |
4 0 |
3.4.22.26 | Carcinoma |
2501168 |
Evidence of a warfarin-sensitive cancer procoagulant in V2 carcinoma. |
therapeutic application unassigned |
1 0 |
3.4.22.26 | Carcinoma |
3294610 |
Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics. |
causal interaction ongoing research therapeutic application unassigned |
1 4 1 0 |
3.4.22.26 | Carcinoma |
3530904 |
gamma-Glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant. |
causal interaction therapeutic application unassigned |
3 1 0 |
3.4.22.26 | Carcinoma |
3935163 |
Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. |
diagnostic usage ongoing research unassigned |
3 4 0 |
3.4.22.26 | Carcinoma |
15600294 |
[Cancer procoagulant activity in serum and neoplastic tissue in cases of cervical and uterine carcinoma] |
causal interaction diagnostic usage ongoing research unassigned |
1 4 3 0 |
3.4.22.26 | Carcinosarcoma |
17061060 |
Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats. |
ongoing research unassigned |
3 0 |
3.4.22.26 | Colorectal Neoplasms |
11761814 |
[Cancer procoagulant activity in cases of esophageal, stomach and colorectal cancer considering progression degree and histological type of cancer] |
diagnostic usage ongoing research therapeutic application unassigned |
2 3 1 0 |
3.4.22.26 | Colorectal Neoplasms |
11820560 |
Cancer procoagulant as a marker in monitoring the therapy in cases of oesophageal, stomach and colorectal cancer. |
diagnostic usage ongoing research therapeutic application unassigned |
4 4 3 0 |